Hyun-Kyung Lee Selected Research

2-imino-1,3-thiazoline

1/2007

A new 2-imino-1,3-thiazoline derivative, KHG22394, inhibits melanin synthesis in mouse B16 melanoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyun-Kyung Lee Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 11/2008
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2013
4	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2011
4	Lung Neoplasms (Lung Cancer) 01/2022 - 02/2013
4	Tuberculosis (Tuberculoses) 12/2021 - 03/2010
4	Epstein-Barr Virus Infections 12/2015 - 05/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 12/2015
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 07/2013
2	Carcinoma (Carcinomatosis) 01/2020 - 02/2019
2	Pulmonary Tuberculosis 09/2019 - 01/2017
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 03/2016 - 01/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 07/2012
2	Virus Diseases (Viral Diseases) 05/2015 - 08/2011
2	Lymphoma (Lymphomas) 08/2014 - 11/2009
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2014 - 06/2014
2	Human Influenza (Influenza) 11/2013 - 08/2013
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 06/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2022
1	Idiopathic Pulmonary Fibrosis 04/2022
1	Adenocarcinoma of Lung 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Empyema 04/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Congenital Abnormalities (Deformity) 02/2019
1	Acute Kidney Injury (Acute Renal Failure) 03/2017
1	Ventilator-Associated Pneumonia 03/2017
1	Teratogenesis 10/2015
1	Hemorrhage 10/2015
1	Extensively Drug-Resistant Tuberculosis 05/2015
1	Keratitis 05/2015
1	Inflammation (Inflammations) 05/2015
1	Carcinogenesis 01/2015
1	Osteosarcoma (Osteogenic Sarcoma) 01/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2020 - 10/2009
4	ErbB Receptors (EGF Receptor)IBA 03/2021 - 02/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019 - 10/2007
3	LigandsIBA 01/2021 - 07/2014
3	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 06/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 12/2011
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Isoniazid (Ftivazide)FDA LinkGeneric 12/2021 - 09/2019
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2021 - 01/2017
2	Rifampin (Rifampicin)FDA LinkGeneric 09/2019 - 03/2010
2	FluoroquinolonesIBA 03/2019 - 03/2016
2	Tyrosine Kinase InhibitorsIBA 01/2017 - 08/2013
2	Pharmaceutical PreparationsIBA 05/2015 - 12/2013
2	Interleukin-8 (Interleukin 8)IBA 01/2015 - 03/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 03/2014
2	Complement System Proteins (Complement)IBA 08/2014 - 12/2010
1	Flame Retardants (Fire Retardants)IBA 06/2022
1	dechlorane plusIBA 06/2022
1	Halogenated Diphenyl EthersIBA 06/2022
1	Antifibrotic AgentsIBA 04/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Persistent Organic PollutantsIBA 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2021
1	PesticidesIBA 01/2021
1	Celecoxib (Celebrex)FDA Link 12/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2020
1	AntibodiesIBA 01/2020
1	VimentinIBA 01/2020
1	Coloring Agents (Dyes)IBA 01/2020
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2020
1	Ethambutol (Myambutol)FDA LinkGeneric 09/2019
1	Biological ProductsIBA 02/2019
1	MorpholinosIBA 02/2019
1	AndrogensIBA 02/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Colistin (Coly-Mycin)FDA Link 03/2017
1	Carbapenems (Carbapenem Antibiotics)IBA 03/2017
1	ampelopsinIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Levofloxacin (Levaquin)FDA Link 03/2016
1	Moxifloxacin (Avelox)FDA Link 03/2016
1	baicaleinIBA 01/2016
1	belotecanIBA 01/2016
1	AcidsIBA 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Monoclonal AntibodiesIBA 12/2015
1	Ticlopidine (Ticlid)FDA LinkGeneric 10/2015
1	Interferon Type IIBA 05/2015
1	InterleukinsIBA 05/2015
1	Viral RNAIBA 05/2015
1	CytokinesIBA 05/2015
1	Polychlorinated Biphenyls (PCBs)IBA 05/2015
1	Galectin 3 (LGALS3)IBA 01/2015
1	CateninsIBA 01/2015
1	Small Interfering RNA (siRNA)IBA 08/2014
1	p38 Mitogen-Activated Protein KinasesIBA 08/2014
1	EphrinsIBA 07/2014
1	Corticotropin-Releasing HormoneIBA 07/2014

Therapy/Procedure

9	Therapeutics 01/2022 - 11/2009
3	Drug Therapy (Chemotherapy) 01/2021 - 07/2012
2	Immunotherapy 01/2022 - 11/2008
2	Ligation 07/2014 - 02/2013
1	Time-to-Treatment 01/2022
1	Radiotherapy 01/2022